FIRST AMENDMENT TO THE LICENSE AND COLLABORATION AGREEMENTLicense and Collaboration Agreement • August 7th, 2019 • Protagonist Therapeutics, Inc • Pharmaceutical preparations
Contract Type FiledAugust 7th, 2019 Company IndustryThis Amendment (the “First Amendment”) is made and entered into as of May 7, 2019 (the “First Amendment Effective Date”) by and between (i) Protagonist Therapeutics, Inc., a Delaware corporation (“Protagonist”) and (ii) Janssen Biotech, Inc., a company organized under the laws of the Commonwealth of Pennsylvania (“Janssen”). Protagonist and Janssen are referred to collectively herein as the “Parties.”